Last updated on November 2017

A Double-blind, Placebo- and Active-Controlled Evaluation of the Safety and Efficacy of Levomilnacipran ER in Adolescent Patients with Major Depressive Disorder


Brief description of study

A Double-blind, Placebo- and Active-Controlled Evaluation of the Safety and Efficacy of Levomilnacipran ER in Adolescent Patients with Major Depressive Disorder

Detailed Study Description

Adolescent Patients with Major Depressive Disorder

Clinical Study Identifier: TX3228

Contact Investigators or Research Sites near you

Start Over

Alexis Wolfe

University of South Florida- Rothman Center for Pediatric Neuropsychiatry
St. Petersburg, FL USA

Jay Dobson

Northwest Clinical Research Center
Bellevue, WA USA